Top Markets
Coin of the day
Dr. Agarwal's Health Care Limited Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

AGARWALEYE
Rangering i aksjer #7063
Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within... Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within India and abroad. The company delivers a comprehensive range of ophthalmic services, including advanced surgical solutions for cataracts like small incision, phacoemulsification, robotic, and glued intraocular lens procedures. It also offers refractive surgeries designed to correct visual errors, thereby lessening or removing the necessity for glasses and contact lenses. Additional surgical specialties include treatments for retinal conditions, corneal transplantation, pinhole pupilloplasty, oculoplasty, and operations for glaucoma and pterygium. Beyond surgical interventions, the company provides professional medical consultations, in-depth diagnostic services for various eye disorders, and non-surgical therapies such as retinal laser treatment and dry eye management. Furthermore, Dr. Agarwal's Health Care Limited sells optical goods, including spectacles, lenses, contact lenses, and frames, as well as a variety of pharmaceutical products for eye care. The company was founded in 2010 and is based in Chennai, India.
Aksjekurs
$5.48
Markedsverdi
$1.74B
Endring (1 dag)
-0.10%
Endring (1 år)
9.22%
Land
IN
Handel Dr. Agarwal's Health Care Limited (AGARWALEYE)

Kategori

Inntekter for Dr. Agarwal's Health Care Limited (AGARWALEYE)
Inntekter i 2026 TTM: 0
Ifølge Dr. Agarwal's Health Care Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Dr. Agarwal's Health Care Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter